KPF
EVH icon

K2 Principal Fund’s Evolent Health EVH Stock Holding History

K2 Principal Fund’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-77,857
Closed -$2.12M – 243
2023
Q3 		$2.12M Buy
+77,857
New +$2.16M 0.44% 57

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

K2 Principal Fund's EVH Position: Q4 2023 in Review

K2 Principal Fund sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 77,857 shares — an estimated $2.12M sold.

K2 Principal Fund first reported a position in EVH in Q3 2023 and held it in 1 quarter. The position peaked at $2.12M in Q3 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

  • K2 Principal Fund reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
  • K2 Principal Fund sold 77,857 Evolent Health shares in Q4 2023, an estimated $2.12M.
  • K2 Principal Fund first reported a position in Evolent Health in Q3 2023 and held it in 1 quarter.
  • K2 Principal Fund's Evolent Health position peaked at $2.12M in Q3 2023.
  • 234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on K2 Principal Fund's 13F filing for Q4 2023, filed 14 Feb 2024.